IL-6 Level May Predict Symptom Duration in Concussed Athletes
Interleukin 6 levels at six hours postconcussion are significantly associated with symptom duration
Considerable Number of Patients Receive Surprise Hospital Charges
18 percent of all ED visits, 16 percent of in-network hospital stays have at least one out-of-network charge
Self-Management Strategies Offer Limited Benefit in Epilepsy
Education-based approaches improve self-management behavior; psychosocial therapy approaches up QoL
In Utero Opioid Exposure Tied to Poor Outcomes Throughout Childhood
Adverse outcomes seen at birth and in preschool and school-aged children
Guidance Issued for Management of Fontan Circulation
More patients surviving to adulthood; management affected by scarcity of knowledge
Adverse Outcomes Up for Pregnant Women With Migraine
Increased risk for several neonatal, postnatal outcomes for offspring exposed to maternal migraine
Leisure-Time Physical Activity Linked to Lower SAH Risk
Protective association for LTPA persisted in all age, hypertension groups; was stronger for smokers
June 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for June 2019. This roundup includes the latest...
Soliris Approved to Treat Neuromyelitis Optica Spectrum Disorder
In clinical trials, Soliris reduced NMOSD relapses by 94 percent compared with placebo
Family History of Dementia Tied to Early Memory Deficits
Reduced paired-associates learning performance observed long before typical onset of Alzheimer disease
